PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026EJC Paediatric Oncology0 citationsOpen Access

Congenital histiocytosis with central nervous system involvement and a novel PTPRJ::RASGRF1 fusion

PKPaul G. KempsMBMarianna BugianiMSM. Scheijde-Vermeulen

Key Points

  • A novel PTPRJ::RASGRF1 fusion identified in a newborn with congenital histiocytosis affecting the CNS and other organs.
  • Histopathology showed atypical histiocytosis with strong CD1a expression, indicating clonal cellular expansion.
  • Observational analysis of the case involved comprehensive genomic profiling and post-mortem transcriptome sequencing.
  • Findings highlight the importance of diverse tumor profiling to understand histiocytic neoplasms better and may enable targeted therapies.

Abstract

ABSTRACT Histiocytic neoplasms are rare diseases characterized by clonal expansions of cells with a macrophage or dendritic cell phenotype. They are driven by mutations activating the MAPK pathway and may involve diverse organs, including the central nervous system (CNS). We describe a newborn with congenital histiocytosis affecting the CNS, skin, thyroid, and soft tissues – including a tumor originating from the tongue obstructing the upper airway. Histopathology revealed an atypical histiocytosis with strong CD1a and variable Langerin expression; post-mortem transcriptome sequencing identified a novel PTPRJ::RASGRF1 fusion. This case expands the molecular landscape of histiocytic neoplasms, highlighting the value of comprehensive genomic profiling.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kemps et al. (2026) studied this question.

synapsesocial.com/papers/69a7611bc6e9836116a2eb53https://doi.org/10.1016/j.ejcped.2026.100492
Ask AI
Helpful
Bookmark
Share
View Full Paper